249.80

0.69% -1.74

After Hours: 249.80

Labcorp Holdings Inc (LH)

Overview News Price History Option Chain Financials Why LH Down? Discussions Forecast Stock Split Dividend History

Labcorp Holdings Inc stock is traded at $249.80, with a volume of 594.91K. It is down -0.69% in the last 24 hours and up +8.93% over the past month. Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Previous Close:

$251.54

Open:

$251.02

24h Volume:

594.91K

Relative Volume:

1.08

Market Cap:

$20.95B

Revenue:

$12.71B

Net Income/Loss:

$435.50M

P/E Ratio:

48.50

EPS:

5.15

Net Cash Flow:

$843.20M

1W Performance:

+1.54%

1M Performance:

+8.93%

6M Performance:

+15.95%

1Y Performance:

+12.37%

1-Day Range:

$249.08

$252.71

1-Week Range:

$245.99

$258.59

52-Week Range:

$191.97

$258.59

Labcorp Holdings Inc Stock (LH) Company Profile

Name

Labcorp Holdings Inc

Sector

Healthcare (1192)

Industry

Diagnostics & Research (59)

Phone

(336) 229-1127

Address

358 S MAIN ST, BURLINGTON, NC

Employee

67,000

Twitter

@labcorp

Next Earnings Date

2024-10-24

Latest SEC Filings

LH's Discussions on Twitter

Compare LH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LH Labcorp Holdings Inc	249.80	20.95B	12.71B	435.50M	843.20M	5.15
TMO Thermo Fisher Scientific Inc	597.75	228.84B	42.37B	6.14B	7.78B	15.95
DHR Danaher Corp	222.74	160.72B	23.74B	3.89B	4.98B	5.24
A Agilent Technologies Inc	151.52	43.49B	6.51B	1.29B	1.37B	4.42
IQV Iqvia Holdings Inc	201.36	36.52B	15.32B	1.41B	1.96B	7.62
IDXX Idexx Laboratories Inc	422.05	34.54B	3.84B	866.24M	792.60M	10.37

Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-07-25	Upgrade	Evercore ISI	In-line → Outperform
Dec-10-24	Resumed	Jefferies	Buy
Oct-30-24	Upgrade	HSBC Securities	Hold → Buy
Oct-01-24	Initiated	Piper Sandler	Neutral
Mar-25-24	Upgrade	Argus	Hold → Buy
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-09-24	Initiated	Evercore ISI	In-line
Jan-03-24	Initiated	Barclays	Equal Weight
Sep-06-23	Initiated	HSBC Securities	Hold
Dec-12-22	Downgrade	Citigroup	Buy → Neutral
Sep-19-22	Downgrade	Argus	Buy → Hold
Aug-22-22	Resumed	Morgan Stanley	Overweight
Jan-28-22	Downgrade	Deutsche Bank	Buy → Hold
Jan-11-21	Upgrade	Argus	Hold → Buy
Jan-11-21	Downgrade	Wolfe Research	Peer Perform → Underperform
Jan-08-21	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-14-20	Upgrade	BofA Securities	Neutral → Buy
Jul-13-20	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-02-20	Resumed	Deutsche Bank	Buy
May-15-20	Upgrade	Mizuho	Neutral → Buy
Apr-29-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-27-20	Upgrade	Citigroup	Neutral → Buy
Apr-27-20	Upgrade	Wolfe Research	Underperform → Peer Perform
Jan-08-20	Initiated	Wells Fargo	Overweight
Jul-16-19	Upgrade	BofA/Merrill	Underperform → Neutral
Jun-21-19	Upgrade	Deutsche Bank	Hold → Buy
Apr-02-19	Upgrade	Jefferies	Hold → Buy
Jan-17-19	Initiated	UBS	Buy
Jan-03-19	Downgrade	BofA/Merrill	Neutral → Underperform
Dec-03-18	Downgrade	Craig Hallum	Buy → Hold
Oct-30-18	Downgrade	Argus	Buy → Hold
Oct-25-18	Downgrade	Canaccord Genuity	Buy → Hold
Oct-19-18	Resumed	BofA/Merrill	Buy
Jun-07-18	Upgrade	KeyBanc Capital Mkts	Sector Weight → Overweight
May-01-18	Upgrade	Robert W. Baird	Neutral → Outperform
Mar-23-18	Initiated	Argus	Buy

View All

Labcorp Holdings Inc Stock (LH) Latest News

09:01 AM

Labcorp Set to Report Q4 Earnings: What's in Store for the Stock? - Yahoo Finance

09:01 AM

Jan 30, 2025

Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Jan 30, 2025

Jan 29, 2025

Labcorp Can't Flip Patent Board Loss At Fed. Circ. - Law360

Jan 29, 2025

Labcorp Maintains Quarterly Cash Dividend at $0.72 a Share; Payable June 8 to Shareholders of Record as of May 18 - Marketscreener.com

Jan 29, 2025

Jim Cramer on Labcorp Holdings Inc. (LH): ‘The Problem Is It’s Healthcare And People Do Not Like The Healthcare Stocks’ - Insider Monkey

Jan 29, 2025

Jan 27, 2025

Europe Pharmacovigilance and Drug Safety Software Market Forecast, Regional Share and Growth Opportunity Analysis to 2031 - GlobeNewswire Inc.

Jan 27, 2025

LabCorp stock hits 52-week high at $248.69 amid robust growth - Investing.com Canada

Jan 27, 2025

Jan 26, 2025

Earnings Flash (LH) LABCORP Posts Q1 EPS $3.82, vs. Street Est of $3.96 -April 25, 2023 at 06:55 am EDT - Marketscreener.com

Jan 20, 2025

Jan 15, 2025

Labcorp Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch

Jan 15, 2025

Labcorp to Provide Testing Device for Eli Lilly-Sponsored Lung Cancer Testing Program - Marketscreener.com

Jan 15, 2025

Jan 14, 2025

Is Labcorp Holdings Stock Underperforming the S&P 500? - MSN

Jan 14, 2025

Jan 12, 2025

Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72 - Simply Wall St

Jan 12, 2025

Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72 - Yahoo Finance

Jan 12, 2025

Jan 10, 2025

Labcorp Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

Jan 10, 2025

Labcorp to Participate in J.P. Morgan Healthcare Conference - TipRanks

Jan 10, 2025

Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times

Jan 10, 2025

Labcorp Declares Quarterly Cash Dividend for 2025 - TipRanks

Jan 10, 2025

Jan 09, 2025

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025 - The Malaysian Reserve

Jan 09, 2025

Jan 08, 2025